TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines Post author:Sam Post published:August 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Vertex Nixes Three Planned Phase III CF Trials in France February 14, 2018 InVivo Therapeutics Announces New Patient Enrollment Into The INSPIRE Study At June 26, 2017 Governor Launches $500 Million Initiative to Keep Massachusetts' Biotech World Booming June 19, 2017